XML 26 R16.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock Options
3 Months Ended
Mar. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock Options

11. Stock Options

 

The Company adopted a stock option plan (“Plan”). The purpose of this Plan is to provide additional incentives to key employees, officers, directors and consultants of the Company and its subsidiaries in order to help attract and retain the best available personnel for positions of responsibility and otherwise promote the success of its business. It is intended that options issued under this Plan constitute non-qualified stock options. The general terms of awards under the option plan are that 100% of the options granted will vest the year following the grant. The maximum term of options granted is 5 years. The exercise price of all options are not less than fair market value at the date of grant.

 

The following table summarizes the Company’s stock option activity for the year ended December 31, 2017 and the three-month period ended March 31, 2018:

 

    Number of shares     Exercise price
per share
    Weighted average exercise price  
                   
Balance, December 31, 2016     813,000       $0.75 - $2.22     $ 1.19  
Granted     154,000     $ 1.70     $ 1.70  
Cancelled or expired     (114,000 )   $ 1.00 – 2.22     $ 1.75  
Exercised     (140,000 )   $ 0.75 – 1.21     $ 1.11  
Balance, December 31, 2017     713,000     $ 0.75 – 1.70     $ 1.21  
Cancelled or expired     -       -       -  
Exercised     (33,000 )   $ 1.00 - 1.42     $ 1.10  
Balance, March 31, 2018     680,000     $ 0.75 – 1.70     $ 1.22  
Exercisable, March 31, 2018     526,000     $ 0.75 – 1.41     $ 1.08  

 

The fair value of each option grant is calculated using the following weighted average assumptions:

 

    2017  
       
Expected life – years     3.0  
Interest rate     2.23 %
Volatility     73.09 %
Dividend yield     %
Weighted average fair value of options granted   $ 0.8344  

 

The Company did not grant any options during the three months ended March 31, 2018 or 2017. Options granted in previous quarters resulted in expenses in the amount of $6,675 for consultants (2017 - $5,658) and $19,025 for employees (2017 - $17,824) during the quarter ended March 31, 2018. There were 23,000 employee and 10,000 consultant stock options exercised during the during the three months ended March 31, 2018 (2017 – 3,000 employee stock options).

 

As of March 31, 2018, there was approximately $77,099 of compensation expense related to non-vested awards. This expense is expected to be recognized over a weighted average period of 0.75 years.